MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas

Diffuse midline gliomas (DMGs) show resistance to many chemotherapeutic agents including temozolomide (TMZ). Histone gene mutations in DMGs trigger epigenetic changes including DNA hypomethylation, one of which is a frequent lack of O6-methyl-guanine-DNA methyltransferase (MGMT) promoter methylation...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Hideaki, Natsumeda, Manabu, Okada, Masayasu, Watanabe, Jun, Tsukamoto, Yoshihiro, Kanemaru, Yu, Yoshimura, Junichi, Oishi, Makoto, Hashizume, Rintaro, Kakita, Akiyoshi, Fujii, Yukihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985080/
https://www.ncbi.nlm.nih.gov/pubmed/32039031
http://dx.doi.org/10.3389/fonc.2019.01568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985080/
https://www.ncbi.nlm.nih.gov/pubmed/32039031
http://dx.doi.org/10.3389/fonc.2019.01568

Ejemplares similares